US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry (Q31133478)

22 August 2017

US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry (English)

1 reference

familial hypercholesterolemia

22 August 2017

0 references

1 reference

Connie B Newman

8

0 references

Matthew T Roe

19

object named as

Matthew T Roe

1 reference

22 August 2017

Christie M. Ballantyne

21

object named as

Christie M Ballantyne

1 reference

22 August 2017

Zahid S Ahmad

1

1 reference

22 August 2017

Rolf L Andersen

2

1 reference

22 August 2017

Lars H Andersen

3

1 reference

22 August 2017

Emily C O'Brien

4

1 reference

22 August 2017

Iris Kindt

5

1 reference

22 August 2017

Peter Shrader

6

1 reference

22 August 2017

Chandna Vasandani

7

1 reference

22 August 2017

Emil M deGoma

9

1 reference

22 August 2017

Seth J Baum

10

1 reference

22 August 2017

Linda C Hemphill

11

1 reference

22 August 2017

Lisa C Hudgins

12

1 reference

22 August 2017

Catherine D Ahmed

13

1 reference

22 August 2017

Iftikhar J Kullo

14

1 reference

22 August 2017

Samuel S Gidding

15

1 reference

22 August 2017

Danielle Duffy

16

1 reference

22 August 2017

William Neal

17

1 reference

22 August 2017

Katherine Wilemon

18

1 reference

22 August 2017

Daniel J Rader

20

1 reference

22 August 2017

MacRae F Linton

22

1 reference

22 August 2017

P Barton Duell

23

1 reference

22 August 2017

Michael D Shapiro

24

1 reference

22 August 2017

Patrick M Moriarty

25

1 reference

22 August 2017

Joshua W Knowles

26

1 reference

22 August 2017

language of work or name

English

0 references

publication date

6 August 2016

1 reference

Journal of Clinical Lipidology

22 August 2017

1 reference

22 August 2017

10

1 reference

22 August 2017

1223-1229

1 reference

22 August 2017

5

1 reference

Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5381273

The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart Association

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5381273

Screening for genetic mutations in LDLR gene with familial hypercholesterolemia patients in the Saudi population

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5381273

Screening and treatment of familial hypercholesterolemia - Lessons from the past and opportunities for the future (based on the Anitschkow Lecture 2014)

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5381273

Prevalence and management of familial hypercholesterolaemia in coronary patients: An analysis of EUROASPIRE IV, a study of the European Society of Cardiology

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5381273

Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5381273

Reducing the burden of disease and death from familial hypercholesterolemia: a call to action

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5381273

Lomitapide for the management of homozygous familial hypercholesterolemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5381273

Efficacy and safety of alirocumab in patients with heterozygous familial hypercholesterolemia not adequately controlled with current lipid-lowering therapy: design and rationale of the ODYSSEY FH studies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5381273

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5381273

Mipomersen and other therapies for the treatment of severe familial hypercholesterolemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5381273

Efficacy of statins in familial hypercholesterolaemia: a long term cohort study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5381273

Familial hypercholesterolemia and coronary heart disease: a HuGE association review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5381273

Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5381273

A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5381273

Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5381273

Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5381273

Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5381273

Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5381273

PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5381273

Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5381273

Familial hypercholesterolaemia: a model of care for Australasia.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5381273

Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5381273

Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5381273

Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial

25 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27678440

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.JACL.2016.07.011

1 reference

22 August 2017

1 reference

22 August 2017

1 reference